Fischer Medical Ventures Limited (NSE:FISCHER)
India · Delayed Price · Currency is INR 36.49
+1.73 (4.98%)
May 22, 2026, 3:29 PM IST
Fischer Medical Ventures Revenue
Fischer Medical Ventures had revenue of 1.01B INR in the quarter ending December 31, 2025, with 760.49% growth. This brings the company's revenue in the last twelve months to 2.60B, up 215.87% year-over-year. In the fiscal year ending March 31, 2025, Fischer Medical Ventures had annual revenue of 1.11B with 427.61% growth.
Revenue (ttm)
2.60B
Revenue Growth
+215.87%
P/S Ratio
9.13
Revenue / Employee
65.00M
Employees
40
Market Cap
23.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.11B | 897.17M | 427.61% |
| Mar 31, 2024 | 209.81M | 208.02M | 11,588.75% |
| Mar 31, 2023 | 1.80M | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | 1.65M | -189.00K | -10.28% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 584.62B |
| Cipla | 277.12B |
| Apollo Hospitals Enterprise | 252.29B |
| Divi's Laboratories | 105.60B |
| Dishman Carbogen Amcis | 29.88B |
| Indoco Remedies | 18.45B |
| Solara Active Pharma Sciences | 13.75B |
| Shalby | 11.19B |
Fischer Medical Ventures News
- 10 months ago - Fischer Medical Ventures launches Chennai’s first high-resolution open MRI at Sunray Scans - Business Upturn